Stay updated on HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.

Latest updates to the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedOn 2026-01-12, the History page adds Contacts/Locations and Study Status sections and records Revision: v3.3.4. The previous Revision: v3.3.3 from 2025-12-02 is removed.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedFooter updates show Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study status was updated to Completed on 2025-12-02. The Recruitment Status now shows Completed, replacing the previous Active, not recruiting entry.SummaryDifference0.3%

- Check52 days agoChange DetectedThe footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check59 days agoChange DetectedPage history shows a minor revision update from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. This banner removal does not change the study record content or status.SummaryDifference0.3%

Stay in the know with updates to HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.